Connecting Data to Improve Your Contamination Control Strategies

Santa Monica, CA – Novatek International’s Head of Product Specialists and Training Services, Sheba Zaman, recently spoke with Gabrielle Bejarano, host of the “Exceeding Your Benchmark” podcast by Benchmark Solutions. The two discussed how the pharmaceutical industry can integrate data use in processes to improve contamination control strategies while adhering to compliance standards and protecting data.

Contamination control is vital in pharma, but the variety of regulations, liabilities, and patient health considerations create data silos that impede development of efficient strategies. Zaman and Bejarano explored how companies can overcome this by integrating data use in their processes.

Zaman also highlighted challenges of managing compliance data in the pharmaceutical industry and discussed how technology can provide visibility in a holistic manner. She emphasized the benefits of technology in decision making and trend analysis and predicted the evolution of compliance software in the next five to ten years.

Furthermore, Zaman addressed concerns about cybersecurity and data integrity, explaining companies must make a significant investment to mitigate risks. She encouraged companies to conduct a data integrity risk assessment and ensure that both their processes and solutions meet data integrity requirements.

Zaman’s insights provide valuable information to pharmaceutical companies looking to improve contamination strategies while maintaining compliance standards and data security.

Follow us on social media for the latest updates in B2B!

Image

Latest

Texas
Up Next: Demographic Change, Education, and the Future of Texas and the Nation
December 2, 2025

Houston’s unmatched diversity and rapidly growing young population are reshaping the city’s economic future — and offering clues about what’s ahead for the nation. In the upcoming episode of Weaver: Beyond the Numbers, the conversation explores how immigration, education, and demographic momentum intersect to create extraordinary opportunities when supported with the right investments.

Read More
patient
Rebecca Interview: When Peer-to-Peer Reviews Stop Being About the Patient
December 2, 2025

Behind the sterile labels of “inpatient” versus “observation” care is a messy reality: clinicians and insurers often enter peer-to-peer reviews without a shared rulebook, turning what should be a clinical dialogue into a box-checking exercise. The speaker’s frustration points to a broader problem in U.S. healthcare utilization management—decisions about coverage can feel pre-decided,…

Read More
physician advisor
Navigating Payer Denials: A Physician Advisor’s Perspective #2
December 2, 2025

A physician advisor recently described a case that should unsettle anyone who cares about fair, clinically grounded coverage decisions: a Medicaid patient arrived comatose from an overdose, was emergently intubated, developed aspiration pneumonia, and stayed through three midnights before leaving against medical advice. By any bedside standard, this is acute, unstable care—exactly what…

Read More
Inside ERISA Denials: Why Employers May Be the Real Decision-Makers Behind Your Insurance Card
December 2, 2025

Insurance denials aren’t new, but they’re hitting a breaking point right now. As prior authorizations surge and patients face longer delays for everything from imaging to specialty drugs, more providers are realizing that the “payer” on the card often isn’t the one truly holding the reins. A growing share of Americans are covered…

Read More